Pharmaceutical R&D Productivity Forum 2008

20th - 21st October 2008

Hyatt San Diego, California

Optimizing R&D pipelines

Phenomenome Discoveries Details

Phenomenome Discoveries

Company Profile:

Phenomenome Discoveries Inc. (PDI) is a human health research company that uses its patented metabolomic biomarker discovery platform and patented informatic research tools to discover novel metabolite biomarkers. PDI has small molecule serum biomarker discovery programs in cancer and neurodegenerative disease, and has validated and filed patents on diagnostic biomarkers in multiple human health disorders.

Key Products:

PDI is uniquely positioned within the market, offering expertise in discovery and subsequent elucidation of the biological relevance of biomarkers as well as the development of highly efficient targeted assays for validated, relevant biomarkers.

PDI is the only biomarker discovery provider that offers high resolution non-targeted metaoblite biomarker discovery using FTMS. Our patented discovery platform produces the highest quality data possible. We kno that robust, reliable and efficient discovery is driven by high resolution data sets that aid in decision making. We accept no less in our own research, and offer the same high standard to our contract research clients.

Website:
www.phenomenome.com